1. Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic

   • François Raffi
   • Robert L. Gottlieb

   Review Open access 17 February 2023 Pages: 735 - 747

2. Systematic Review on the Correlation Between SARS-CoV-2 Real-Time PCR Cycle Threshold Values and Epidemiological Trends

   • Ester Sala
   • Isheeta S. Shah
   • Sonia N. Rao

   Review Open access 22 February 2023 Pages: 749 - 775

   

3. Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales

   • Keith S. Kaye
   • Thierry Naas
   • Gian Maria Rossolini

   Review Open access 25 February 2023 Pages: 777 - 806

4. Targeted Literature Review of the Burden of Respiratory Syncytial Infection among High-Risk and Elderly Patients in Asia Pacific Region

   • Daisuke Kurai
   • JoonYoung Song
   • Peter C. Richmond

   Review Open access 03 March 2023 Pages: 807 - 828

   

5. β-Lactam Resistance in ESKAPE Pathogens Mediated Through Modifications in Penicillin-Binding Proteins: An Overview

   • Dhiviya Prabaa Muthuirulandi Sethuvel
   • Yamuna Devi Bakthavatchalam
   • Balaji Veeraraghavan

   Review Open access 06 March 2023 Pages: 829 - 841

   

6. Comparison of Virological Efficacy of DTG/ABC/3TG and B/F/TAF Regimens and Discontinuation Patterns in Persons Living with Advanced HIV in the Era of Rapid ART: A Retrospective Multicenter Cohort Study

   • Chun-Yuan Lee
   • Chen-Hsiang Lee
   • Po-Liang Lu

   Original Research Open access 15 December 2022 Pages: 843 - 861

   

7. Correction to: Comparison of Virological Efficacy of DTG/ABC/3TG and B/F/TAF Regimens and Discontinuation Patterns in Persons Living with Advanced HIV in the Era of Rapid ART: A Retrospective Multicenter Cohort Study

   • Chun-Yuan Lee
   • Chen-Hsiang Lee
   • Po-Liang Lu

   Correction Open access 16 February 2023 Pages: 863 - 869

8. Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort Study

   • Shuai-Wen Huang
   • Xi-Tang Li
   • Jia-Quan Huang

   Original Research Open access 08 February 2023 Pages: 871 - 890

   

9. The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study

   • Alex Soriano
   • Philippe Montravers
   • Claudie Charbonneau

   Original Research Open access 10 February 2023 Pages: 891 - 917

   

10. Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review

    • Chia-Hao Chang
    • Lih-Yu Chang
    • Chong-Jen Yu

    Original Research Open access 11 February 2023 Pages: 919 - 931

    

11. Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

    • Liping Huang
    • Cheryl L. McDade
    • Renilla Sewdas

    Original Research Open access 12 February 2023 Pages: 933 - 950

    

12. Risk Factors for Melioidosis Mortality and Epidemics: A Multicentre, 10-Year Retrospective Cohort Study in Northern Hainan

    • Wanting Zheng
    • Shicheng Kuang
    • Biao Wu

    Original Research Open access 17 February 2023 Pages: 951 - 964

    

13. Causal Associations Between Tobacco, Alcohol Use and Risk of Infectious Diseases: A Mendelian Randomization Study

    • Hongxiang Zhu
    • Xiaohui Zhan
    • Lingyan Zhao

    Original Research Open access 02 March 2023 Pages: 965 - 977

    

14. Prognostic Value of Serum Ferritin for Patients with Severe Fever with Thrombocytopenia Syndrome: A Single-Center Retrospective Cohort Study

    • Jiao Xie
    • Mengzhao Su
    • Lei Zhao

    Original Research Open access 08 March 2023 Pages: 979 - 988

    

15. Evaluating the Follow-up of Post-discharge Positive Sterile Site Cultures and the Impact on Infection-Related Complications

    • Reid LaPlante
    • Kimberly C. Claeys
    • Mandee Noval

    Original Research Open access 08 March 2023 Pages: 989 - 996

16. Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective

    • Xiuyan Li
    • Sophie Warren
    • Johnna Perdrizet

    Brief Report Open access 03 March 2023 Pages: 997 - 1006

    

17. Fournier’s Gangrene with Growth of Actinomyces europaeus: A Case Report

    • Shurong Zhang
    • Yunkai Xie
    • Yonghui Zou

    Case Report Open access 23 February 2023 Pages: 1007 - 1011

    

18. A Letter to the Editor Regarding ‘Identifying Gaps in the Corticosteroid Treatment of COVID-19: We Need More Studies’

    • Fatma Yildirim
    • İrem Karaman
    • Aşkın Güneş

    Letter Open access 08 March 2023 Pages: 1013 - 1016

19. Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial

    • Sanjeev Sinha
    • Anuj Ajayababu
    • Ravindra Mohan Pandey

    Correction Open access 16 February 2023 Pages: 1017 - 1018